Replies to post #121540 on Biotech Values

[DewDiligence]

Meda AB, which is publicly traded in Stockholm, will receive a 6-8% royalty on sales on Potiga:

http://finance.yahoo.com/news/MEDA-Potiga-ezogabine-bw-282433081.html?x=0&.v=1

[genisi]

GSK/VRX are working on a modified release tablet formulations of ezogabine:

http://clinicaltrials.gov/ct2/show/NCT01332513?term=NCT01332513&rank=1